{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:11:33Z","timestamp":1777266693807,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2024\/R\/1445"],"award-info":[{"award-number":["PSAU\/2024\/R\/1445"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s11064-024-04226-5","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T07:02:25Z","timestamp":1724742145000},"page":"3118-3130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Interplay of Carveol and All-Trans Retinoic Acid (ATRA) in Experimental Parkinson\u2019s Disease: Role of Inflammasome-Mediated Pyroptosis and Nrf2"],"prefix":"10.1007","volume":"49","author":[{"given":"Asmaa Jan","family":"Muhammad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal F","family":"Al-baqami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawaz E.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Alattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem","family":"Alshaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najeeb Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yassine","family":"Riadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawad Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"4226_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s40263-018-0548-y","volume":"32","author":"D Athauda","year":"2018","unstructured":"Athauda D, Foltynie T (2018) Drug repurposing in Parkinson\u2019s disease. CNS Drugs 32:747\u2013761. https:\/\/doi.org\/10.1007\/s40263-018-0548-y","journal-title":"CNS Drugs"},{"key":"4226_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuropharm.2017.09.023","volume":"136","author":"D Athauda","year":"2018","unstructured":"Athauda D, Foltynie T (2018) Protective effects of the GLP-1 mimetic exendin-4 in Parkinson\u2019s disease. Neuropharmacol 136:260\u2013270. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.09.023","journal-title":"Neuropharmacol"},{"key":"4226_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fneur.2019.00122","volume":"10","author":"E Caggiu","year":"2019","unstructured":"Caggiu E, Arru G, Hosseini S, Niegowska M, Sechi G, Zarbo IR, Sechi LA (2019) Inflammation, infectious triggers, and Parkinson\u2019s disease. Front Neurol 10:122. https:\/\/doi.org\/10.3389\/fneur.2019.00122","journal-title":"Front Neurol"},{"key":"4226_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.biopha.2015.01.029","volume":"70","author":"S Sharma","year":"2015","unstructured":"Sharma S, Singh S, Sharma V, Singh VP, Deshmukh R (2015) Neurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategies. Biomed Pharmacother 70:283\u2013293. https:\/\/doi.org\/10.1016\/j.biopha.2015.01.029","journal-title":"Biomed Pharmacother"},{"key":"4226_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fnana.2015.00091","volume":"9","author":"J Blesa","year":"2015","unstructured":"Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR (2015) Oxidative stress and Parkinson\u2019s disease. Front Neuroanat 9:91. https:\/\/doi.org\/10.3389\/fnana.2015.00091","journal-title":"Front Neuroanat"},{"key":"4226_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH (2024) The pathogenesis of Parkinson\u2019s disease. Lancet 403:293\u2013304. https:\/\/doi.org\/10.1016\/S0140-6736(23)01478-2","journal-title":"Lancet"},{"key":"4226_CR7","doi-asserted-by":"publisher","first-page":"10478","DOI":"10.3390\/ijms130810478","volume":"13","author":"H Kumar","year":"2012","unstructured":"Kumar H, Lim HW, More SV, Kim BW, Koppula S, Kim IS, Choi DK (2012) The role of free radicals in the aging brain and Parkinson\u2019s Disease: convergence and parallelism. Int J Mol Sci 13:10478\u201310504. https:\/\/doi.org\/10.3390\/ijms130810478","journal-title":"Int J Mol Sci"},{"key":"4226_CR8","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3390\/antiox10111649","volume":"10","author":"JA Parga","year":"2021","unstructured":"Parga JA, Rodriguez-Perez AI, Garcia-Garrote M, Rodriguez-Pallares J, Labandeira-Garcia JL (2021) NRF2 activation and downstream effects: focus on Parkinson\u2019s disease and brain angiotensin. Antioxidants 10:1649. https:\/\/doi.org\/10.3390\/antiox10111649","journal-title":"Antioxidants"},{"key":"4226_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fnins.2020.00659","volume":"14","author":"I Malik","year":"2020","unstructured":"Malik I, Shah FA, Ali T, Tan Z, Alattar A, Ullah N, Khan A-u, Alshaman R, Li S (2020) Potent natural antioxidant carveol attenuates MCAO-stress induced oxidative, neurodegeneration by regulating the Nrf-2 pathway. Front Neurosci 14:659. https:\/\/doi.org\/10.3389\/fnins.2020.00659","journal-title":"Front Neurosci"},{"key":"4226_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.intimp.2018.11.044","volume":"66","author":"Q Li","year":"2019","unstructured":"Li Q, Tian Z, Wang M, Kou J, Wang C, Rong X, Li J, Xie X, Pang X (2019) Luteoloside attenuates neuroinflammation in focal cerebral ischemia in rats via regulation of the PPAR\u03b3\/Nrf2\/NF-\u03baB signaling pathway. Int Immunopharmacol 66:309\u2013316. https:\/\/doi.org\/10.1016\/j.intimp.2018.11.044","journal-title":"Int Immunopharmacol"},{"key":"4226_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/antiox12040817","volume":"12","author":"G Sani","year":"2023","unstructured":"Sani G, Margoni S, Brugnami A, Ferrara OM, Bernardi FE, Simonetti A, Monti L, Mazza M, Janiri D, Moccia L, Kotzalidis GD, Chieffo DRP, Janiri L, L (2023) The Nrf2 pathway in depressive disorders: a systematic review of animal and human studies. Antioxidants 12:817. https:\/\/doi.org\/10.3390\/antiox12040817","journal-title":"Antioxidants"},{"key":"4226_CR12","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3892\/mmr.2020.11003","volume":"21","author":"CT Jiang","year":"2020","unstructured":"Jiang CT, Wu WF, Deng YH, Ge JW (2020) Modulators of microglia activation and polarization in ischemic stroke. Mol Med Rep 21:2006\u20132018. https:\/\/doi.org\/10.3892\/mmr.2020.11003","journal-title":"Mol Med Rep"},{"key":"4226_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1017\/S1461145709009924","volume":"12","author":"RA Khairova","year":"2009","unstructured":"Khairova RA, Machado-Vieira R, Du J, Manji HK, H. K (2009) A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 12:561\u2013578. https:\/\/doi.org\/10.1017\/S1461145709009924","journal-title":"Int J Neuropsychopharmacol"},{"key":"4226_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4103\/1673-5374.322423","volume":"17","author":"J Cornell","year":"2022","unstructured":"Cornell J, Salinas S, Huang HY, Zhou M (2022) Microglia regulation of synaptic plasticity and learning and memory. Neural Regen Res 17:705\u2013716. https:\/\/doi.org\/10.4103\/1673-5374.322423","journal-title":"Neural Regen Res"},{"key":"4226_CR15","doi-asserted-by":"publisher","first-page":"1122104","DOI":"10.3389\/fphar.2023.1122104","volume":"14","author":"Y Liao","year":"2023","unstructured":"Liao Y, Wang X, Huang L, Qian H, Liu W (2023) Mechanism of pyroptosis in neurodegenerative diseases and its therapeutic potential by traditional Chinese medicine. Front Pharmacol 14:1122104. https:\/\/doi.org\/10.3389\/fphar.2023.1122104","journal-title":"Front Pharmacol"},{"key":"4226_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12974-021-02137-8","volume":"18","author":"Q Xu","year":"2021","unstructured":"Xu Q, Zhao B, Ye Y, Li Y, Zhang Y, Xiong X, Gu L (2021) Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke. J Neuroinflammation 18:123. https:\/\/doi.org\/10.1186\/s12974-021-02137-8","journal-title":"J Neuroinflammation"},{"key":"4226_CR17","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s11064-017-2185-0","volume":"42","author":"Z Mao","year":"2017","unstructured":"Mao Z, Liu C, Ji S, Yang Q, Ye H, Han H, Xue Z (2017) The NLRP3 inflammasome is involved in the pathogenesis of Parkinson\u2019s disease in rats. Neurochem Res 42:1104\u20131115. https:\/\/doi.org\/10.1007\/s11064-017-2185-0","journal-title":"Neurochem Res"},{"key":"4226_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","volume":"67","author":"S Wang","year":"2019","unstructured":"Wang S, Yuan Y-H, Chen N-H, Wang H-B (2019) The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson\u2019s disease. Int Immunopharmacol 67:458\u2013464. https:\/\/doi.org\/10.1016\/j.intimp.2018.12.019","journal-title":"Int Immunopharmacol"},{"key":"4226_CR19","doi-asserted-by":"publisher","unstructured":"Alvi AM, Al Kury LT, Alattar A, Ullah I, Muhammad AJ, Alshaman R, Shah FA, Khan AU, Feng J, Li S (2021) Carveol attenuates seizure severity and neuroinflammation in pentylenetetrazole-kindled epileptic rats by regulating the Nrf2 signaling pathway. Oxid Med Cell Longev 2021. https:\/\/doi.org\/10.1155\/2021\/9966663","DOI":"10.1155\/2021\/9966663"},{"key":"4226_CR20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3389\/fphar.2020.00919","volume":"11","author":"MS Ahmed","year":"2020","unstructured":"Ahmed MS, Khan AU, Kury LTA, Shah FA (2020) Computational and pharmacological evaluation of carveol for antidiabetic potential. Front Pharmacol 11:919. https:\/\/doi.org\/10.3389\/fphar.2020.00919","journal-title":"Front Pharmacol"},{"key":"4226_CR21","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1159\/000485947","volume":"44","author":"W Xu","year":"2018","unstructured":"Xu W, Zheng D, Liu Y, Li J, Yang L, Shang X (2018) Glaucocalyxin B alleviates lipopolysaccharide-induced Parkinson\u2019s disease by inhibiting TLR\/NF-\u03baB and activating Nrf2\/HO-1 pathway. Cell Physiol Biochem 44:2091\u20132104. https:\/\/doi.org\/10.1159\/000485947","journal-title":"Cell Physiol Biochem"},{"key":"4226_CR22","doi-asserted-by":"publisher","first-page":"100060","DOI":"10.1016\/j.bbih.2020.100060","volume":"4","author":"I Deng","year":"2020","unstructured":"Deng I, Corrigan F, Zhai G, Zhou XF, Bobrovskaya L (2020) Lipopolysaccharide animal models of Parkinson\u2019s disease: recent progress and relevance to clinical disease. Brain Behav Immun Health 4:100060. https:\/\/doi.org\/10.1016\/j.bbih.2020.100060","journal-title":"Brain Behav Immun Health"},{"key":"4226_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbi.2012.10.001","volume":"27","author":"DB Hoban","year":"2013","unstructured":"Hoban DB, Connaughton E, Connaughton C, Hogan G, Thornton C, Mulcahy P, Moloney TC, Dowd E (2013) Further characterisation of the LPS model of Parkinson\u2019s disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat. Brain Behav Immun 27:91\u2013100. https:\/\/doi.org\/10.1016\/j.bbi.2012.10.001","journal-title":"Brain Behav Immun"},{"key":"4226_CR24","doi-asserted-by":"publisher","first-page":"42323","DOI":"10.1038\/srep42323","volume":"7","author":"H Takeshita","year":"2017","unstructured":"Takeshita H, Yamamoto K, Nozato S, Inagaki T, Tsuchimochi H, Shirai M, Yamamoto R, Imaizumi Y, Hongyo K, Yokoyama S (2017) Modified forelimb grip strength test detects aging-associated physiological decline in skeletal muscle function in male mice. Sci Rep 7:42323. https:\/\/doi.org\/10.1038\/srep42323","journal-title":"Sci Rep"},{"key":"4226_CR25","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.2147\/DDDT.S207310","volume":"13","author":"LT Al Kury","year":"2019","unstructured":"Al Kury LT, Zeb A, Abidin ZU, Irshad N, Malik I, Alvi AM, Khalil AAK, Ahmad S, Faheem M, Khan A-U (2019) Neuroprotective effects of melatonin and celecoxib against ethanol-induced neurodegeneration: a computational and pharmacological approach. Drug Des Devel Ther 13:2715\u20132727. https:\/\/doi.org\/10.2147\/DDDT.S207310","journal-title":"Drug Des Devel Ther"},{"key":"4226_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/biom10010108","volume":"10","author":"M Imran","year":"2020","unstructured":"Imran M, Al Kury LT, Nadeem H, Shah FA, Abbas M, Naz S, Khan A-u, Li S (2020) Benzimidazole containing acetamide derivatives attenuate neuroinflammation and oxidative stress in ethanol-induced neurodegeneration. Biomolecules 10:108. https:\/\/doi.org\/10.3390\/biom10010108","journal-title":"Biomolecules"},{"key":"4226_CR27","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3390\/molecules27051620","volume":"27","author":"AM Chiorcea-Paquim","year":"2022","unstructured":"Chiorcea-Paquim AM (2022) 8-oxoguanine and 8-oxodeoxyguanosine biomarkers of oxidative DNA damage: a review on HPLC\u2013ECD determination. Molecules 27:1620. https:\/\/doi.org\/10.3390\/molecules27051620","journal-title":"Molecules"},{"key":"4226_CR28","doi-asserted-by":"publisher","first-page":"19589","DOI":"10.1073\/pnas.0709483104","volume":"104","author":"XJ Wang","year":"2007","unstructured":"Wang XJ, Hayes JD, Henderson CJ, Wolf CR (2007) Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha. Proc Natl Acad Sci U S A 104:19589\u201319594. https:\/\/doi.org\/10.1073\/pnas.0709483104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4226_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neuro.2018.09.005","volume":"69","author":"D Liu","year":"2018","unstructured":"Liu D, Xue J, Liu Y, Gu H, Wei X, Ma W, Luo W, Ma L, Jia S, Dong N, Huang J, Wang Y, Yuan Z (2018) Inhibition of NRF2 signaling and increased reactive oxygen species during embryogenesis in a rat model of retinoic acid-induced neural tube defects. Neurotoxicology 69:84\u201392. https:\/\/doi.org\/10.1016\/j.neuro.2018.09.005","journal-title":"Neurotoxicology"},{"key":"4226_CR30","doi-asserted-by":"publisher","first-page":"105376","DOI":"10.1016\/j.phrs.2020.105376","volume":"164","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Long Y, Yu S, Li D, Yang M, Guan Y, Zhang D, Wan J, Liu S, Shi A, Li N, Peng W, W (2021) Natural volatile oils derived from herbal medicines: a promising therapy way for treating depressive disorder. Pharmacol Res 164:105376. https:\/\/doi.org\/10.1016\/j.phrs.2020.105376","journal-title":"Pharmacol Res"},{"key":"4226_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","volume":"34","author":"T Suzuki","year":"2013","unstructured":"Suzuki T, Motohashi H, Yamamoto M (2013) Toward clinical application of the Keap1\u2013Nrf2 pathway. TIPS 34:340\u2013346. https:\/\/doi.org\/10.1016\/j.tips.2013.04.005","journal-title":"TIPS"},{"key":"4226_CR32","doi-asserted-by":"publisher","unstructured":"Gray NE, Farina M, Tucci P, Saso L (2022) The role of the NRF2 pathway in maintaining and improving cognitive function. Biomedicines 10: 2043. https:\/\/doi.org\/10.3390\/biomedicines10082043","DOI":"10.3390\/biomedicines10082043"},{"key":"4226_CR33","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.redox.2018.11.017","volume":"21","author":"F Sivandzade","year":"2019","unstructured":"Sivandzade F, Prasad S, Bhalerao A, Cucullo L (2019) NRF2 and NF-\u049bB interplay in cerebrovascular and neurodegenerative disorders: molecular mechanisms and possible therapeutic approaches. Redox Biol 21:101059. https:\/\/doi.org\/10.1016\/j.redox.2018.11.017","journal-title":"Redox Biol"},{"key":"4226_CR34","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.psyneuen.2013.03.020","volume":"38","author":"MD Mart\u00edn-de-Saavedra","year":"2013","unstructured":"Mart\u00edn-de-Saavedra MD, Budni J, Cunha MP, G\u00f3mez-Rangel V, Lorrio S, Del Barrio L, Lastres-Becker I, Parada E, Tordera RM, Rodrigues ALS (2013) Nrf2 participates in depressive disorders through an anti-inflammatory mechanism. Psychoneuroendocrinology 38:2010\u20132022. https:\/\/doi.org\/10.1016\/j.psyneuen.2013.03.020","journal-title":"Psychoneuroendocrinology"},{"key":"4226_CR35","doi-asserted-by":"publisher","first-page":"425619","DOI":"10.3389\/fneur.2019.00271","volume":"10","author":"X Guo","year":"2019","unstructured":"Guo X, Han C, Ma K, Xia Y, Wan F, Yin S, Kou L, Sun Y, Wu J, Hu J (2019) Hydralazine protects nigrostriatal dopaminergic neurons from MPP\u2009+\u2009and MPTP induced neurotoxicity: roles of Nrf2-ARE signaling pathway. Front Neurol 10:425619. https:\/\/doi.org\/10.3389\/fneur.2019.00271","journal-title":"Front Neurol"},{"key":"4226_CR36","doi-asserted-by":"publisher","first-page":"175029","DOI":"10.1016\/j.ejphar.2022.175029","volume":"926","author":"Y Su","year":"2022","unstructured":"Su Y, Liu N, Zhang Z, Li H, Ma J, Yuan Y, Shi M, Liu J, Zhao Z, Zhang Z (2022) Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and \u03b1-synuclein accumulation in the colon of two Parkinson\u2019s disease mouse models. Eur J Pharmacol 926:175029. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175029","journal-title":"Eur J Pharmacol"},{"key":"4226_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","volume":"26","author":"E Lee","year":"2019","unstructured":"Lee E, Hwang I, Park S, Hong S, Hwang B, Cho Y (2019) MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ 26:213\u2013228. https:\/\/doi.org\/10.1038\/s41418-018-0124-5","journal-title":"Cell Death Differ"},{"key":"4226_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01751-2","volume":"17","author":"Z Liu","year":"2020","unstructured":"Liu Z, Yao X, Jiang W, Li W, Zhu S, Liao C, Zou L, Ding R, Chen J (2020) Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-\u03baB signaling pathway and pyroptosis after secondary spinal cord injury. J Neuroinflam 17:1\u201321. https:\/\/doi.org\/10.1186\/s12974-020-01751-2","journal-title":"J Neuroinflam"},{"key":"4226_CR39","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.3390\/ijms24032646","volume":"24","author":"A Hosseini","year":"2023","unstructured":"Hosseini A, Stojkov D, Fettrelet T, Bilyy R, Yousefi S, Simon HU (2023) Transcriptional insights of oxidative stress and extracellular traps in lung tissues of fatal COVID-19 cases. Int J Mol Sci 24:2646. https:\/\/doi.org\/10.3390\/ijms24032646","journal-title":"Int J Mol Sci"},{"key":"4226_CR40","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/01.brs.0000259841.40358.8f","volume":"32","author":"B Gok","year":"2007","unstructured":"Gok B, Okutan O, Beskonakli E, Palaoglu S, Erdamar H, Sargon MF (2007) Effect of immunomodulation with human interferon-beta on early functional recovery from experimental spinal cord injury. Spine 32:873\u2013880. https:\/\/doi.org\/10.1097\/01.brs.0000259841.40358.8f","journal-title":"Spine"},{"key":"4226_CR41","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3233\/JPD-223290","volume":"12","author":"LTN Nguyen","year":"2022","unstructured":"Nguyen LTN, Nguyen HD, Kim YJ, Nguyen TT, Lee YK, Ma HI, Kim YE (2022) Role of NLRP3 inflammasome in Parkinson\u2019s disease and therapeutic considerations. J Parkinsons Dis 12:2117\u20132133. https:\/\/doi.org\/10.3233\/JPD-223290","journal-title":"J Parkinsons Dis"},{"key":"4226_CR42","doi-asserted-by":"publisher","first-page":"1039241","DOI":"10.3389\/fimmu.2022.1039241","volume":"13","author":"D Zheng","year":"2022","unstructured":"Zheng D, Liu J, Piao H, Zhu Z, Wei R, Liu K (2022) ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis. Front Immunol 13:1039241. https:\/\/doi.org\/10.3389\/fimmu.2022.1039241","journal-title":"Front Immunol"},{"key":"4226_CR43","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 37:510\u2013518. https:\/\/doi.org\/10.1016\/j.nbd.2009.11.004","journal-title":"Neurobiol Dis"},{"key":"4226_CR44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8:382\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(09)70062-6","journal-title":"Lancet Neurol"},{"key":"4226_CR45","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","volume":"28","author":"HM Gao","year":"2008","unstructured":"Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, Lee VM (2008) Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J Neurosci 28:7687\u20137698. https:\/\/doi.org\/10.1523\/JNEUROSCI.0143-07.2008","journal-title":"J Neurosci"},{"key":"4226_CR46","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1212\/wnl.66.10_suppl_4.s24","volume":"66","author":"P Jenner","year":"2006","unstructured":"Jenner P, Olanow W (2006) The pathogenesis of cell death in Parkinson\u2019s disease. Neurol 66:S24\u2013S36. https:\/\/doi.org\/10.1212\/wnl.66.10_suppl_4.s24","journal-title":"Neurol"},{"key":"4226_CR47","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla LF, Song P, Mazzulli JR, Zampese E, Wong YC, Jeon S (2017) Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science 357:1255\u20131261. https:\/\/doi.org\/10.1126\/science.aam9080","journal-title":"Science"},{"key":"4226_CR48","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12974-019-1564-7","volume":"16","author":"GC Brown","year":"2019","unstructured":"Brown GC (2019) The endotoxin hypothesis of neurodegeneration. J Neuroinflammation 16:180. https:\/\/doi.org\/10.1186\/s12974-019-1564-7","journal-title":"J Neuroinflammation"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04226-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-024-04226-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04226-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T12:08:49Z","timestamp":1727957329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-024-04226-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["4226"],"URL":"https:\/\/doi.org\/10.1007\/s11064-024-04226-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"25 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study obtained ethical approval from the REC-RIPS internal review board under the reference number REC\/RIPS\/ 2021\/008 was allocated.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}